FDA Statement: Statement from FDA Commissioner Scott Gottlieb, M.D., on the signing of the Right to Try Act

If your email program has trouble displaying this email, view it as a web page

Statement from FDA Commissioner Scott Gottlieb, M.D., on the signing of the Right to Try Act  For patients with serious or immediately life-threatening diseases, the FDA remains committed to enhancing access to promising investigational medicines for those unable to access products through clinical trials. This is the mission of our expanded access program. The agency is dedicated to these purposes, and it has been for more than three decades.  Continue reading...

U.S. Food and Drug Administration 10903 New Hampshire Avenue, Silver Spring, MD 20993 1-888-INFO-FDA (1-888-463-6332) Privacy Policy | www.fda.gov Manage Preferences or Unsubscribe from this List | Unsubscribe from all Email Lists